SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
about
SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activatorSRT1720 improves survival and healthspan of obese miceIn Search of New Therapeutic Targets in Obesity Treatment: SirtuinsNew Therapeutic Concept of NAD Redox Balance for Cisplatin NephrotoxicityObestatin: a new metabolic player in the pancreas and white adipose tissueSirtuin 1 and sirtuin 3: physiological modulators of metabolismTargeting sirtuin 1 to improve metabolism: all you need is NAD(+)?T cell replicative senescence in human agingMicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1Sirtuin deacylases: a molecular link between metabolism and immunitySIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activityRole of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell linesG protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese miceMammalian sirtuins: biological insights and disease relevance'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue.Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.Optimal therapy of type 2 diabetes: a controversial challengeSmall-molecule allosteric activators of sirtuins.Circadian rhythms and metabolic syndrome: from experimental genetics to human disease.SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity.Diabetes mellitus: channeling care through cellular discoveryAMPK and SIRT1: a long-standing partnership?Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapyA new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity.Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cellsMyeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress.Knock-down of IL-1Ra in obese mice decreases liver inflammation and improves insulin sensitivity.Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.The full capacity of AICAR to reduce obesity-induced inflammation and insulin resistance requires myeloid SIRT1Novel avenues of drug discovery and biomarkers for diabetes mellitus.Combinatorial regulation of a signal-dependent activator by phosphorylation and acetylation.Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans.The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in miceHypothalamic microinflammation: a common basis of metabolic syndrome and aging.Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemiaRestriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1Sirtuin-1 regulation of mammalian metabolism
P2860
Q24626329-E99726D9-B2B2-481D-BBA5-A059640D5888Q24627930-5659A652-2323-4CC8-A709-D9071854522DQ26750982-71FF5662-6590-4058-996C-60E26EA19342Q26765483-D196C606-5E15-4F36-A574-25F7ED518D7BQ26824623-DD17F39A-5F3C-4589-A9EC-BFAEC18989B3Q26828607-6CC93CCE-5AC6-4EAC-A055-4EE0B6B9DBA4Q26864685-9FFC4C36-BB37-4654-8EFD-1825B71CE3E4Q27022690-D960A67F-7608-4E6E-A9D1-D3DEE060AE87Q28261153-27F1DD28-AE66-4555-9B13-22FDC7D05121Q28283588-1B044070-0086-41A6-B1B5-084F12097959Q28484104-7AB83CB5-72FE-4C73-9DDB-46E0420F6D66Q28568728-68252F05-AC5C-440F-A038-BF3C4D27CF3CQ28589449-D18C5328-9214-4D2A-9473-26B51CA0709FQ29614496-C0F9E5A9-4746-4CA2-9757-62D33EFCE774Q30385053-5B0B9613-A349-4351-9BD1-817EE505A400Q30669518-E190FA70-24FD-470E-A923-040514E4847CQ33577712-748C6615-E752-408F-B029-91740B03F418Q33601236-CED404EA-2037-4433-A87D-2728EC9CC68CQ33722806-6FBFBF08-FE0E-4C6A-8490-E441838D7A05Q33727409-C71B37F5-AD3D-4BEF-B2AC-BFCFB7C30CEFQ33749358-92814B19-AC0A-4971-8F2D-51C7D5F9CD19Q33783499-D8EEC4D8-1767-4EC6-9D0F-9EBD240C9612Q33791807-AAC93A76-7557-4A85-8392-F211D7DF39CCQ33840323-A18CF234-0157-4785-96D0-AB7531F93D80Q33852650-A556971C-728C-49D7-AFD8-DDCC0FBA9394Q33877687-BAD05F11-5BDB-4E9E-AFED-7E3609FC682EQ33911210-0E7B42B0-8997-4C14-90C0-C5C7C4C15EF9Q34023370-8685018A-35DB-4994-B813-F8BCF9BEEBA4Q34178034-752C9CAB-1693-4847-8A43-D7EAAF669F69Q34226895-F2E00B65-51D4-4435-8BB5-E429E46148C0Q34356019-6AB7D1C5-2F31-4CCF-B35C-6AC35C3CEA47Q34489201-78E76B13-6188-4CF1-A043-0153149EE412Q34552287-EC2A52DB-6C8D-47A0-AADD-23E7A69F5977Q34661346-0DE00736-70BF-404E-A14B-E1AB592862C1Q34703328-784B5EFB-364F-4A43-B13E-024BDA4638F5Q34726907-B222BCA5-407F-4F25-A204-61C91AB52DBEQ34808934-1710A367-AFBF-438F-ABEE-4D19C1019868Q35023264-22F48D1D-83B0-4E77-A7AD-7336CB3CE86EQ35060239-0725E874-4554-48C5-91C9-E170B6D74022Q35068878-8B509C9F-7077-4CB7-BA5B-24EA0C6B93B3
P2860
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
@en
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
@nl
type
label
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
@en
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
@nl
prefLabel
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
@en
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
@nl
P2093
P2860
P356
P1476
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.
@en
P2093
Jennie L Babendure
Jesse J Smith
Jill C Milne
Juu-Chin Lu
Michael R Jirousek
Noriyuki Sonoda
Simon Schenk
Takeshi Imamura
Takeshi Yoshizaki
P2860
P304
P356
10.1128/MCB.00705-08
P407
P577
2008-12-22T00:00:00Z